Latest COVID-19 News
COVID-19 Vaccine Clinical Guidance Now Available
The ACR has developed new guidance for rheumatology providers on the use of the COVID-19 vaccines for patients with rheumatic and musculoskeletal diseases. All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.
Vaccine Clinical Guidance Summary - February 8, 2021
Provider Relief Fund Reporting Portal Fact Sheet
Organizations that received Provider Relief Fund (PRF) payments from the Department of Health and Human Services (HHS) must register in the PRF Reporting Portal. While there is not a set deadline to register, organizations are encouraged to enter their information to receive forthcoming notices about requirements.
PRF Reporting Portal Fact Sheet - February 3, 2021
Second Draw of Paycheck Protection Program Loans Fact Sheet
The Small Business Administration recently released guidance on changes to the Paycheck Protection Program (PPP) as well as information regarding a Second Draw of PPP Loans. Learn what you need to know before next week, including eligibility requirements, the amount you can receive, how funds are to be used, and what the application process looks like.
Second Draw PPP Loans Fact Sheet - January 12, 2021
See All Breaking COVID-19 News
Practice and Advocacy Resources
The ACR’s COVID-19 Practice and Advocacy Task Force continues to work rapidly to provide support to you during this unprecedented time. You’ll find guidance documents that include approaches to drug shortages, support for telehealth, information about federal stimulus relief aid, and guidance for infusions. Working with experts in COVID-related topics, we are focused on developing meaningful information and resources to help guide you.
Practice and Advocacy Resources
COVID-19 Manufacturer Resources and Patient Assistance Programs
Clinical Guidance for Pediatric Patients
The ACR has developed two new clinical guidance documents for pediatric patients in the context of the COVID-19 pandemic, including for the care of children with pediatric rheumatic disease, and for the management of inflammatory syndromes in children with recent or concurrent infections with SARS-CoV-2, specifically Multisystem Inflammatory Syndrome in Children (MIS-C). All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.
Clinical Guidance for Pediatric Patients
Clinical Guidance for Adult Patients with Rheumatic Diseases
The ACR has developed clinical guidance for the care of adult patients with rheumatic diseases during the COVID-19 pandemic. Populations considered include patients with a documented COVID-19 infection, those who are stable following exposure to SARS-CoV-2 (but without known infection), and patients who are stable with no infection or exposure. The recommendations address various treatment options and provide general guidance, as well as direction for when to start, stop, or reduce medications. All recommendations are based on current knowledge and will be revised as circumstances and evidence evolve.
Clinical Guidance for Adult Patients with Rheumatic Diseases
Questions and Feedback
Are you experiencing COVID-19 related drug shortages, practice issues, or any other problems? Share your comments and questions with us at COVID@rheumatology.org
Thank you to the corporate supporters of the ACR COVID-19 Emergency Response.
Updated February 11, 2021 at 5:00 PM ET